IDC MarketScape Names Axway a Leader in the Pharmaceutical Track and Trace Software Market
Announcement posted by Axway 23 May 2016
SYDNEY – May 23, 2016 – Axway (Euronext: AXW.PA), a market leader in digital business enablement, today announced that Axway has been named a Leader in the 2016 IDC MarketScape for Pharmaceutical Track and Trace Software for its Axway Track & Trace solution. The comprehensive evaluation of leading pharmaceutical track and trace software vendors evaluated for industry-specific expertise, strong customer references and proven experience in delivering value to pharmaceutical organizations in today’s increasingly digital era. Axway was recognized for its software functionality, customer service, and growth in the market.
“Axway is one of the larger companies evaluated in this study, and its track record of profitable growth positions the company well for further investment in R&D for future capabilities,” said Mike Townsend, research manager, commercial life sciences, IDC Health Insights.
The IDC MarketScape: Worldwide Track and Trace Software Vendor Assessment¹ evaluated 10 vendors in the Track and Trace global market. Axway was named a Leader for its “improved features and support models.” The report also noted that customers consider Axway to be “highly knowledgeable about the pharmaceutical industry” and rated Axway “highly for its communications with clients.”
Axway Track & Trace helps pharmaceutical organizations address the industry’s challenging and evolving global serialization requirements, including U.S. DSCSA regulations, and is built on an EPCIS GS1 EPC global certified, standards based framework. Powered by Axway’s robust integration foundation and ecosystem engagement capabilities, the solution offers pharmaceutical organizations the visibility, flexibility and agility needed to digitally enable any legacy infrastructure for serialization, resulting in improved quality and patient outcomes.
“At Axway we strive to enable our customers in the pharmaceutical industry to accelerate their digital business capabilities while addressing complex regulatory and compliance directives,” said Jeanine Banks, executive vice president, global products and solutions, Axway. “Being named a ‘Leader’ in the IDC MarketScape for the Pharmaceutical Track and Trace Software market is highly encouraging. It represents our commitment to delivering innovative and robust integration solutions that connect with customers and partners in new and exciting ways.”
To download an excerpt of the IDC MarketScape: Worldwide Pharmaceutical Track and Trace Software 2016 Vendor Assessment, please visit here.
Follow Axway on Twitter: @Axway
¹IDC MarketScape: Worldwide Pharmaceutical Track and Trace Software 2016 Vendor Assessment (doc #US40511116, March 2016)
About Axway
Axway (Euronext: AXW.PA) empowers more than 11,000 customers worldwide to collaborate smarter, innovate faster and engage better with their partners, developers and customers. From integration technology that securely connects people, processes and things to an engagement platform that enables API management, identity management, mobile app development and analytics, Axway solutions are enabling digital business. Axway is registered in France with headquarters in the United States. More information is available at www.axway.com.
About IDC MarketScape
IDC MarketScape vendor analysis model is designed to provide an overview of the competitive fitness of ICT (information and communications technology) suppliers in a given market. The research methodology utilizes a rigorous scoring methodology based on both qualitative and quantitative criteria that results in a single graphical illustration of each vendor's position within a given market. IDC MarketScape provides a clear framework in which the product and service offerings, capabilities and strategies, and current and future market success factors of IT and telecommunications vendors can be meaningfully compared. The framework also provides technology buyers with a 360-degree assessment of the strengths and weaknesses of current and prospective vendors.